Your browser doesn't support javascript.
loading
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
Celli, Bartolome R; Decramer, Marc; Wedzicha, Jadwiga A; Wilson, Kevin C; Agustí, Alvar; Criner, Gerard J; MacNee, William; Make, Barry J; Rennard, Stephen I; Stockley, Robert A; Vogelmeier, Claus; Anzueto, Antonio; Au, David H; Barnes, Peter J; Burgel, Pierre-Regis; Calverley, Peter M; Casanova, Ciro; Clini, Enrico M; Cooper, Christopher B; Coxson, Harvey O; Dusser, Daniel J; Fabbri, Leonardo M; Fahy, Bonnie; Ferguson, Gary T; Fisher, Andrew; Fletcher, Monica J; Hayot, Maurice; Hurst, John R; Jones, Paul W; Mahler, Donald A; Maltais, François; Mannino, David M; Martinez, Fernando J; Miravitlles, Marc; Meek, Paula M; Papi, Alberto; Rabe, Klaus F; Roche, Nicolas; Sciurba, Frank C; Sethi, Sanjay; Siafakas, Nikos; Sin, Don D; Soriano, Joan B; Stoller, James K; Tashkin, Donald P; Troosters, Thierry; Verleden, Geert M; Verschakelen, Johny; Vestbo, Jorgen; Walsh, John W.
Afiliação
  • Celli BR; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Decramer M; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Wedzicha JA; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Wilson KC; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Agustí A; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Criner GJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • MacNee W; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Make BJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Rennard SI; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Stockley RA; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Vogelmeier C; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Anzueto A; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Au DH; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Barnes PJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Burgel PR; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Calverley PM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Casanova C; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Clini EM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Cooper CB; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Coxson HO; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Dusser DJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Fabbri LM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Fahy B; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Ferguson GT; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Fisher A; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Fletcher MJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Hayot M; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Hurst JR; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Jones PW; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Mahler DA; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Maltais F; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Mannino DM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Martinez FJ; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Miravitlles M; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Meek PM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Papi A; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Rabe KF; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Roche N; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Sciurba FC; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Sethi S; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Siafakas N; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Sin DD; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Soriano JB; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Stoller JK; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Tashkin DP; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Troosters T; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Verleden GM; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Verschakelen J; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Vestbo J; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
  • Walsh JW; Further details of this ATS/ERS Task Force for COPD Research can be found in the acknowledgements section. Project co-chairs; should be considered co-first authors.
Eur Respir J ; 45(4): 879-905, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25829431
ABSTRACT
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Guias de Prática Clínica como Assunto / Medicina Baseada em Evidências / Doença Pulmonar Obstrutiva Crônica / Pesquisa Biomédica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur Respir J Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Médicas / Guias de Prática Clínica como Assunto / Medicina Baseada em Evidências / Doença Pulmonar Obstrutiva Crônica / Pesquisa Biomédica Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Male País/Região como assunto: America do norte / Europa Idioma: En Revista: Eur Respir J Ano de publicação: 2015 Tipo de documento: Article
...